BNOEF
Price:
$0.006
Market Cap:
$7.11M
Bionomics Limited, a clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers. The company's lead drug candidate includes BNC210, a negative allosteric modulator of the a7 nicotinic acetylcholine receptor, which is in phase 2 clinical trial for the treatment of social anxiety disorder and phase 2b to treat post-traumatic stress disorder. It also develops BNC101, a monoclonal antibody that has completed phase 1 clinical trial that targets cancer stem cells; and BNC105, which is in phase 2 clinical trial for the treatment of refractory colorectal cancer and phase 1 clinical trial for the treatment o...[Read more]
Industry
Biotechnology
IPO Date
2014-06-24
Stock Exchange
PNK
Ticker
BNOEF
According to Bionomics Limited’s latest financial reports and current stock price. The company's current PE Ratio is -0.60. This represents a change of -24.84% compared to the average of -0.80 of the last 4 quarters.
The mean historical PE Ratio of Bionomics Limited over the last ten years is -5.39. The current -0.60 PE Ratio has changed 1.01% with respect to the historical average. Over the past ten years (40 quarters), BNOEF's PE Ratio was at its highest in in the June 2019 quarter at 11.94. The PE Ratio was at its lowest in in the December 2020 quarter at -1532.31.
Average
-5.39
Median
-4.43
Minimum
-11.10
Maximum
-0.85
Discovering the peaks and valleys of Bionomics Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 174.18%
Maximum Annual PE Ratio = -0.85
Minimum Annual Increase = -72.01%
Minimum Annual PE Ratio = -11.10
Year | PE Ratio | Change |
---|---|---|
2023 | -0.85 | -69.91% |
2022 | -2.81 | -71.26% |
2021 | -9.79 | -11.85% |
2020 | -11.10 | 90.51% |
2019 | -5.83 | 174.18% |
2018 | -2.13 | -72.01% |
2017 | -7.59 | 150.83% |
The current PE Ratio of Bionomics Limited (BNOEF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-4.48
5-year avg
-6.08
10-year avg
-5.39
Bionomics Limited’s PE Ratio is greater than BetterLife Pharma Inc. (-3.87), less than PharmaTher Holdings Ltd. (0), greater than IntelGenx Technologies Corp. (-5.31), greater than Captiva Verde Wellness Corp. (-2.69), greater than null (-1.52),
Company | PE Ratio | Market cap |
---|---|---|
-3.87 | $14.05M | |
0 | $17.02M | |
-5.31 | $29.69M | |
-2.69 | $7.48M | |
-1.52 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bionomics Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Bionomics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Bionomics Limited's PE Ratio?
How is the PE Ratio calculated for Bionomics Limited (BNOEF)?
What is the highest PE Ratio for Bionomics Limited (BNOEF)?
What is the 3-year average PE Ratio for Bionomics Limited (BNOEF)?
What is the 5-year average PE Ratio for Bionomics Limited (BNOEF)?
How does the current PE Ratio for Bionomics Limited (BNOEF) compare to its historical average?